Page last updated: 2024-11-11

concanamycin b

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

concanamycin B: from Streptomyces diastatochromogenes S-45; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID5468506
MeSH IDM0112191

Synonyms (8)

Synonym
concanamycin b
mch 210
nsc-670977
81552-33-2
nsc670977
oxacyclooctadeca-3,13,15-tetraen-2-one, 18-[(1s,2r,3s)-3-[(2r,4r,5s,6r)-4-[[4-o-(aminocarbonyl)- 2,6-dideoxy-.beta.-d-arabino-hexopyranosyl]oxy]tetrahydro- 2-hydroxy-5-methyl-6-(1e)-1-propenyl-2h-pyran-2-yl]- 2-hydroxy-1-methylbutyl]-8,10-dihydroxy-3,17-d
concanamycin a,8-deethyl-8-methyl-
[6-[(4r)-2-[(4s)-4-[(4e,6e,11s,12r,13r,14e,16z)-10,12-dihydroxy-3,17-dimethoxy-7,9,11,13,15-pentamethyl-18-oxo-1-oxacyclooctadeca-4,6,14,16-tetraen-2-yl]-3-hydroxypentan-2-yl]-2-hydroxy-5-methyl-6-[(e)-prop-1-enyl]oxan-4-yl]oxy-4-hydroxy-2-methyloxan-3-yl

Research Excerpts

Actions

ExcerptReferenceRelevance
"Concanamycin B was found to inhibit PTH-stimulated osteoclastic pit formation and to suppress the acidification of vacuolar organelles by V-ATPase in the osteoclasts."( Concanamycin B, a vacuolar H(+)-ATPase specific inhibitor suppresses bone resorption in vitro.
Ohba, Y; Sumitani, K; Tagami, K; Tsuji, T; Woo, JT; Yamaguchi, K, 1996
)
2.46

Treatment

ExcerptReferenceRelevance
"In concanamycin B-treated cells, a slow increase (> 20-fold) in surface expression of Ii, mostly complexed with alpha beta, is detected."( How MHC class II molecules reach the endocytic pathway.
BĂ©naroch, P; Geuze, HJ; Ito, K; Miwa, K; Ploegh, HL; Raposo, G; Yilla, M, 1995
)
0.81
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (15)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (13.33)18.7374
1990's9 (60.00)18.2507
2000's3 (20.00)29.6817
2010's1 (6.67)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 17.27

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index17.27 (24.57)
Research Supply Index2.77 (2.92)
Research Growth Index4.86 (4.65)
Search Engine Demand Index10.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (17.27)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (6.67%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other14 (93.33%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]